⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IBRX News
ImmunityBio, Inc. Common Stock
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX
accessnewswire.com
IBRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX
accessnewswire.com
IBRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX
accessnewswire.com
IBRX
ImmunityBio Partners with Biopharma and Cigalah Healthcare to Launch ANKTIVA® in Saudi Arabia for Bladder and Lung Cancer Patients
businesswire.com
IBRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX
prnewswire.com
IBRX
ImmunityBio Expands Access to ANKTIVA ® in EU with New Distribution Partnership and Opens Irish Subsidiary to Support European Launch
businesswire.com
IBRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX
accessnewswire.com
IBRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX
globenewswire.com
IBRX
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
prnewswire.com
IBRX
NVCR
ONCY
NUVB
CATX
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
prnewswire.com
NVCR
IBRX
ONCY
CATX
NUVB